131 related articles for article (PubMed ID: 2411862)
1. D2 dopamine receptors in calf globus pallidus: agonist high- and low-affinity sites not regulated by guanine nucleotide.
De Keyser J; De Backer JP; Convents A; Ebinger G; Vauquelin G
J Neurochem; 1985 Sep; 45(3):977-9. PubMed ID: 2411862
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
George SR; Watanabe M; Seeman P
J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
[TBL] [Abstract][Full Text] [Related]
3. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
Kazmi SM; Ramwani J; Srivastava LK; Rajakumar G; Ross GM; Cullen M; Mishra RK
J Neurochem; 1986 Nov; 47(5):1493-502. PubMed ID: 3760872
[TBL] [Abstract][Full Text] [Related]
4. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
Makman MH; Dvorkin B; Klein PN
Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
[TBL] [Abstract][Full Text] [Related]
5. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
Lazareno S; Nahorski SR
Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
[TBL] [Abstract][Full Text] [Related]
6. Correspondency between different affinity states and target size of the bovine striatal D2 dopamine receptor.
Kuno T; Tanaka C
Biochem Biophys Res Commun; 1983 Nov; 117(1):65-70. PubMed ID: 6197972
[TBL] [Abstract][Full Text] [Related]
7. Lack of GTP-insensitive D2 dopamine receptors in Huntington's disease.
De Keyser J; Roos RA; Ebinger G; Vauquelin G
J Neurol Sci; 1989 Sep; 92(2-3):329-35. PubMed ID: 2530315
[TBL] [Abstract][Full Text] [Related]
8. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
9. In human brain two subtypes of D1 dopamine receptors can be distinguished on the basis of differences in guanine nucleotide effect on agonist binding.
De Keyser J; Walraevens H; Ebinger G; Vauquelin G
J Neurochem; 1989 Oct; 53(4):1096-102. PubMed ID: 2527968
[TBL] [Abstract][Full Text] [Related]
10. Characterization of binding sites for 3H-spiroperidol in human retina.
McGonigle P; Wax MB; Molinoff PB
Invest Ophthalmol Vis Sci; 1988 May; 29(5):687-94. PubMed ID: 2452802
[TBL] [Abstract][Full Text] [Related]
11. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
12. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
Hamblin MW; Leff SE; Creese I
Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
[TBL] [Abstract][Full Text] [Related]
13. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.
Richfield EK; Young AB; Penney JB
Brain Res; 1986 Sep; 383(1-2):121-8. PubMed ID: 3768686
[TBL] [Abstract][Full Text] [Related]
14. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
Graff-Guerrero A; Willeit M; Ginovart N; Mamo D; Mizrahi R; Rusjan P; Vitcu I; Seeman P; Wilson AA; Kapur S
Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
Zahniser NR; Molinoff PB
Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
[TBL] [Abstract][Full Text] [Related]
16. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
17. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
[TBL] [Abstract][Full Text] [Related]
18. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
Wreggett KA; Seeman P
Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
[TBL] [Abstract][Full Text] [Related]
19. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
MacKenzie RG; Zigmond MJ
J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330
[TBL] [Abstract][Full Text] [Related]
20. D2 dopamine receptors in the human brain: heterogeneity based on differences in guanine nucleotide effect on agonist binding, and their presence on corticostriatal nerve terminals.
De Keyser J; Walraevens H; De Backer JP; Ebinger G; Vauquelin G
Brain Res; 1989 Apr; 484(1-2):36-42. PubMed ID: 2523750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
